Categories Earnings, Energy

Chevron’s Q3 results miss expectations

Chevron Corporation (NYSE: CVX) missed revenue and earnings expectations for the third quarter of 2019. Shares were down 0.90% in premarket hours on Friday.

Total revenues fell 18% year-over-year to $36.1 billion and missed the consensus target of $38 billion.  

Chevron reports Q3 2019 earnings results

Net income attributable to Chevron was $2.5 billion, or $1.36 per share, compared to $4 billion, or $2.11 per share, in the prior-year period. Analysts were expecting EPS of $1.45.

CEO Michael Wirth said, “Lower crude oil and natural gas prices more than offset a 3% increase in net oil-equivalent production from last year’s third quarter.”

In the Upstream division, worldwide net oil-equivalent production was 3.03 million barrels per day, up 3% from a year ago.

Earnings from the US upstream operations fell 12% to $727 million, and earnings from the international upstream operations dropped 22% to $1.98 billion year-over-year, mainly due to lower crude oil and natural gas realizations.

Also read: ExxonMobil Q3 2019 Earnings Report

Earnings in the US downstream operations declined 47% year-over-year to $389 million due to higher operating expenses, and lower margins on refined product sales. Earnings from international downstream operations decreased 29% to $439 million, largely due to the absence of 2018 gains from the southern Africa asset sale.  

In September, Chevron sanctioned a waterflood project in the St. Malo Field in the Gulf of Mexico. The company also acquired deepwater exploration blocks in the Mexican Gulf of Mexico and Brazil’s Campos and Santos basins, strengthening its deepwater exploration portfolio.

Get access to timely and accurate verbatim transcripts that are published within hours of the event.

Most Popular

United Parcel Service (UPS) seems on track to regain lost strength

Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top